Free Trial

Natural Alternatives International (NAII) Competitors

Natural Alternatives International logo
$3.37 +0.09 (+2.74%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$3.32 -0.05 (-1.48%)
As of 09/10/2025 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NAII vs. ENTX, ORMP, KALA, IPA, OKYO, OVID, VXRT, WHWK, ATRA, and QNCX

Should you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), KALA BIO (KALA), ImmunoPrecise Antibodies (IPA), OKYO Pharma (OKYO), Ovid Therapeutics (OVID), Vaxart (VXRT), Whitehawk Therapeutics (WHWK), Atara Biotherapeutics (ATRA), and Quince Therapeutics (QNCX). These companies are all part of the "pharmaceutical products" industry.

Natural Alternatives International vs. Its Competitors

Entera Bio (NASDAQ:ENTX) and Natural Alternatives International (NASDAQ:NAII) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation and risk.

Natural Alternatives International has higher revenue and earnings than Entera Bio. Entera Bio is trading at a lower price-to-earnings ratio than Natural Alternatives International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Entera Bio$180K471.82-$9.54M-$0.26-7.15
Natural Alternatives International$113.80M0.18-$7.22M-$1.39-2.42

14.1% of Entera Bio shares are held by institutional investors. Comparatively, 32.4% of Natural Alternatives International shares are held by institutional investors. 10.4% of Entera Bio shares are held by insiders. Comparatively, 20.9% of Natural Alternatives International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Entera Bio has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500. Comparatively, Natural Alternatives International has a beta of 0.57, indicating that its share price is 43% less volatile than the S&P 500.

In the previous week, Entera Bio had 4 more articles in the media than Natural Alternatives International. MarketBeat recorded 5 mentions for Entera Bio and 1 mentions for Natural Alternatives International. Entera Bio's average media sentiment score of 1.25 beat Natural Alternatives International's score of 0.00 indicating that Entera Bio is being referred to more favorably in the media.

Company Overall Sentiment
Entera Bio Positive
Natural Alternatives International Neutral

Entera Bio presently has a consensus target price of $10.00, indicating a potential upside of 437.63%. Given Entera Bio's stronger consensus rating and higher probable upside, research analysts plainly believe Entera Bio is more favorable than Natural Alternatives International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Entera Bio
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00
Natural Alternatives International
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Natural Alternatives International has a net margin of -6.56% compared to Entera Bio's net margin of -4,525.11%. Natural Alternatives International's return on equity of -10.34% beat Entera Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Entera Bio-4,525.11% -77.75% -68.13%
Natural Alternatives International -6.56%-10.34%-5.19%

Summary

Entera Bio and Natural Alternatives International tied by winning 8 of the 16 factors compared between the two stocks.

Get Natural Alternatives International News Delivered to You Automatically

Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NAII vs. The Competition

MetricNatural Alternatives InternationalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$20.27M$2.61B$5.83B$10.07B
Dividend YieldN/A48.62%5.25%4.53%
P/E Ratio-2.4223.7375.5726.01
Price / Sales0.18656.95536.77117.75
Price / CashN/A169.9337.4259.95
Price / Book0.255.2711.536.20
Net Income-$7.22M$32.95M$3.29B$270.65M
7 Day Performance-11.55%1.95%0.87%2.84%
1 Month Performance-8.80%9.75%7.67%7.23%
1 Year Performance-47.18%0.64%61.32%26.49%

Natural Alternatives International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NAII
Natural Alternatives International
0.2049 of 5 stars
$3.37
+2.7%
N/A-47.8%$20.27M$113.80M-2.42290
ENTX
Entera Bio
1.6674 of 5 stars
$1.99
+2.8%
$10.00
+403.8%
+0.0%$90.64M$180K-7.6320Positive News
Short Interest ↓
ORMP
Oramed Pharmaceuticals
0.4913 of 5 stars
$2.19
-0.7%
N/A-2.9%$89.59M$1.34M-6.2410
KALA
KALA BIO
3.644 of 5 stars
$12.71
+13.3%
$13.00
+2.3%
+158.8%$89.29M$3.89M-1.8730News Coverage
Analyst Forecast
High Trading Volume
IPA
ImmunoPrecise Antibodies
2.5706 of 5 stars
$1.91
-19.4%
$4.00
+109.4%
+219.5%$88.15M$17.59M-2.8180Upcoming Earnings
Gap Up
OKYO
OKYO Pharma
2.7541 of 5 stars
$2.34
-0.4%
$7.00
+199.1%
+98.2%$87.22MN/A0.007Positive News
OVID
Ovid Therapeutics
4.4163 of 5 stars
$1.22
-5.1%
$3.10
+155.1%
+12.6%$86.40M$570K-2.2960Gap Down
VXRT
Vaxart
2.1027 of 5 stars
$0.37
-4.4%
$2.00
+436.2%
-59.3%$85.39M$47.40M-1.38120News Coverage
WHWK
Whitehawk Therapeutics
N/A$1.80
-0.3%
N/AN/A$84.83M$25.98M-30.0040
ATRA
Atara Biotherapeutics
4.4524 of 5 stars
$11.98
-0.6%
$21.00
+75.4%
+37.1%$84.06M$128.94M-27.85330Positive News
QNCX
Quince Therapeutics
3.5826 of 5 stars
$1.56
-2.5%
$8.14
+422.0%
+125.9%$83.57MN/A-1.4360Positive News

Related Companies and Tools


This page (NASDAQ:NAII) was last updated on 9/11/2025 by MarketBeat.com Staff
From Our Partners